-
To advance women’s leadership, an effort ‘has to be purposeful,’ says EMD Serono exec
01 Apr 2024 12:26 GMT
… America medical affairs, at EMD Serono. “It's incredibly … expertise.”
Since joining EMD Serono in 2018, Lebson has … America medical affairs, EMD Serono
Here, Lebson discusses the ways … can continue also to improve benefit offerings, [such as] maternity …
-
Amivantamab Offers Post-Progression Benefit in EGFRm NSCLC
28 Mar 2024 07:22 GMT
… line setting offers ongoing benefit to patients with epidermal … provide a more meaningful benefit over chemotherapy alone.
… the progression-free survival benefit of the combination at … Merck Sharp & Dohme, Merck Serono, Novartis, PeerVoice, Peptomyc, Pfizer …
-
China In-Vitro Fertilization Market Research Report 2023-2030 Featuring Vitrolife, Cloudnine, Nova IVI Fertility, Monash, Maria Fertility Hospital, Bangkok Fertility Center, and EMD Serono - ResearchAndMarkets.com
22 Mar 2024 13:20 GMT
… , stringent hygiene requirements, and the benefit of one-time use. Using … . Bangkok Fertility Center
7. EMD Serono, Inc.
Treatment Types - China …
-
Individual and Group Level Cognitive Benefits of Cladribine Displayed in MAGNIFY-MS Study
02 Mar 2024 02:29 GMT
… (NCT03364036) assessing cladribine (Mavenclad; EMD Serono) in patients with highly active … patients on the agent. Cognitive benefit was evident following the first …
-
EMD Serono Presents New MAVENCLAD® Data Supporting Cognitive Function Benefits
29 Feb 2024 13:14 GMT
… showed a clinically meaningful benefit in cognitive processing speed … further support the continued benefits of MAVENCLAD following completion … science.
About EMD Serono, Inc.
EMD Serono - the healthcare … in life science, EMD Serono in healthcare and EMD …
-
How EMD Serono plans to hit its lofty goals in R&D
27 Nov 2023 15:11 GMT
… research, EMD Serono
Permission granted by EMD Serono
“What the … chain, which has the benefit of increasing our footprint … metastatic colorectal cancer.
EMD Serono’s most advanced oncology … companies’ perspective, EMD Serono offers expertise and a …
-
VIDEO: Sitravatinib plus nivolumab does not offer OS benefit over docetaxel in NSCLC subset
14 Nov 2023 22:58 GMT
Disclosures:
Borghaei reports receiving research support for clinical trials from Amgen, Bristol Myers Squibb and Lilly; consulting for Amgen, AstraZeneca, Axiom, Bayer, Beigene, BerGenBio, BioNTech, Boehringer Ingelheim, Bristol Myers Squibb, Daiichi, EMD …
-
EMD Serono to Present Latest Research from Oncology Portfolio at ESMO 2023
16 Oct 2023 20:47 GMT
… Booth #526.
Select EMD Serono-related abstracts accepted for … verification and description of clinical benefit in confirmatory trials.
Important … world.
About EMD Serono, Inc.
EMD Serono - the healthcare … in life science, EMD Serono in healthcare and EMD …
-
VIDEO: Second-line tepotinib plus osimertinib benefits metastatic EGFR-mutated NSCLC
13 Oct 2023 18:08 GMT
October 13, 2023
1 min watch
Healio spoke with Melina Elpi Marmarelis, MD, about data from the INSIGHT 2 trial presented at this year’s International Association for the Study of Lung Cancer World Conference on Lung Cancer.
The study assessed the use of …
-
Evobrutinib, CNS-Penetrant BTKi, Has Shown Sustained Clinical Benefit Up to Five Years in People with RMS
11 Oct 2023 06:24 GMT
… the long-term positive benefits of evobrutinib for people … findings may indicate sustained benefit of long-term twice-daily … scores. Overall, the treatment benefit on PROMIS Fatigue T- … science.
About EMD Serono, Inc.
EMD Serono - the healthcare business …